Join us on October 19th, in Marseille,
for a unique event for the immunology sector.
⇒ TO REGISTER CLICK HERE
Marseille Hémicycle de MPM Jardin du Pharo
Le Pharo 58, boulevard Charles Livon 13007, Marseille
On October 19th, under the High Patronage of Mr. Emmanuel MACRON, President of the French Republic, the 2nd meeting on Immunology will be held in Marseille. Organized by Eurobiomed health cluster, this meeting will take place in a very peculiar context after the recent announcement of the selection of the MIB* biocluster financed at 97 M€ within the framework of France 2030 health plan. The day will be an opportunity to meet major players in the field of immunology: researchers, clinicians, start-ups, and manufacturers at the forefront of the development of tomorrow’s immunotherapies. New targets, innovative technologies and ongoing clinical trials are some of the topics that we’ll discuss during the sessions. You will also discover a world-class ecosystem at the cutting edge of innovation in Immunology.
PROGRAM
09:00 Welcome
09:30 Introduction
- Mr Pierre d’EPENOUX, (CEO Imcheck Therapeutics, VP Eurobiomed)
09:40 Agence d’Innovation en Santé (AIS)
- To be confirmed
09:50 New target discovery for immune-based therapy
- Dr. Sophie UGOLINI, DR Inserm (CIML)
- Dr. Geoffrey GUITTARD, PhD (CRCM)
10:35 COFFEE BREAK
10:50 New target discovery for immune-based therapy
- Dr Sophie AGAUGUE, PhD (Imcheck Therapeutics)
- Dr. Cornec DIVI, PU-PH (CHU Brest)
11:35 Clinical advances in auto-immune diseases
- Pr. Christian JORGENSEN, PU-PH, (IHU Immune4Cure, CHU Montpellier)
12:10 LUNCH
13:30 Innovative plateforms to derisk & accelerate target development
- Pr. Françoise DIGNAT-GEORGE, PharmD (C2VN)
- Dr. Ana ZARUBICA, PhD (CIPHE)
- Pr. Eric GUEDJ, PU-PH (APHM, CERIMED)
14:40 At clinical stage, state of the art technologies to restimulate & retrain the immune system
- Dr David FENARD, PhD, HDR (Sangamo Therapeutics France)
- Dr Stéphanie CORNEN, PharmD, PhD (Innate Pharma)
15:25 COFFEE BREAK
15:40 Industrial point of view for immunotherapy development
- Dr Nicolas BASSE, PhD (Sanofi)
- Dr Sandra HUBERT, PhD (Servier)
16:30 Round table – To be confirmed
- MIB, an International Biocluster in Immunology
17:00 Cocktail
⇒ TO REGISTER CLICK HERE
AN EVENT IN PARTNERSHIP WITH :
 |
|
THANKS TO THE SUPPORT OF OUR SPONSORS :
Gold Sponsor |
Silver Sponsor |
 |
 |
 |
*????????????, Marseille Immunology Biocluster, aims at developing in Marseille an international biocluster for immunology, on a Bostonian model, by bringing together leading players (research & education, hospitals, CRO and biopharmaceutical companies) to accelerate the development of new immunotherapies against incurable or severely disabling pathologies: chronic inflammatory diseases, auto -immune diseases, cancers and infectious diseases. Local and national stakeholders are involved in the project: Aix-Marseille University, Inserm and CNRS, AP-HM and IPC, Brest Hospital, SATT Sud-Est, Eurobiomed, biotech companies and CROs, two global pharmaceutical companies, as well as the Aix-Marseille-Provence Metropolis, the Bouches-du-Rhône Department and the Provence-Alpes-Côte-d’Azur Region, in order to position the region at the forefront of global competition in immunology therapies.
|
